Patents

US8609858: Spiro derivatives of parthenin as novel anticancer agents

The invention relates to novel spiro derivatives of parthenin prepared by the dipolar cycloaddition of various dipoles viz, benzonitrile oxides, nitrones, azides, nitrile ylide diazoalkane, nitrile imide, ozone, azomethine imides, azomethine ylides etc. with exocyclic double bond of C ring (?-methylene-?-butyrolactone). Representative compounds have been screened for their anticancer activity against different cancer cell lines. ICs0 value of these analogues varies between 4.3 µM to 93 µM. A mechanistic correlation of their anticancer activity has been described. The results of the cytotoxicity test of the compounds studies indicated that the ?, ?-unsaturated ketonic moiety in parthenin plays an important role in the maintenance of the high level of cytotoxicity.

Filing Date: 29-04-2011

Issue Date: 17-12-2013

Applicant: CSIR-Indian Institute of Integrative Medicine (CSIR-IIIM), Jammu

Patent No: US8609858

Application No: 12/921061

Inventor(s): Halmuthur Mahabalarao Sampath Kumar; Saxena Ajit Kumar; Taneja Subhash Chandra; Singh Shashank Kumar; Sethi Vijay Kumar; Qazi Naveed Ahmed; Sawant Sanghapal Damodar; Doma Mahender Reddy; Banday Abid Hussain; Verma Monika; Qazi Ghulam Nabi

IPC Classification: C07D 498/10, C07D 491/107

Country: United States of America

Related Patents